Drug-induced nephrotoxicity of aminoglycosides and the role of medicinal plants as nephroprotective agents
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 03:17 ET (29-Oct-2026 07:17 GMT/UTC)
The study, "Drug-Induced Nephrotoxicity of Aminoglycosides and the Role of Medicinal Plants as Nephroprotective Agents," was carried out by Astha Chaudhary, Monika Singh, Moumita Barman, and S. Sadish Kumar in the Journal of Current Indian Science.
A new review article examines how a widely used class of antibiotics damages the kidneys, how that damage is detected and measured clinically, and how a range of medicinal plants—backed by documented bioactive compounds—may offer a safer, side-effect-free means of protecting kidney tissue in patients who cannot avoid these drugs.
Fine particulate matter (PM2.5) – pollution particles measuring 2.5 micrometers or less – is released by human activity but also by natural sources like wildfires. These pollutants are a health risk for everyone, but pregnant people and unborn babies are particularly vulnerable. A new study shows that while total exposure to polluted air in the US has decreased over the past decades, almost two thirds of the days when unborn babies are exposed to unhealthy levels of PM2.5 pollution are now due to wildfires. The team said this highlights that a shift of perspective is needed to efficiently target interventions and allocate resources to those most in need.
Relying on Artificial Intelligence (AI) in health care also carries a risk that existing racial and gender stereotypes will be reflected in the medical content it generates.
A spinout from the University of Osaka is developing a slim, lightweight, single-use endoscope designed specifically for gastric cancer screening. By simplifying conventional endoscope design, the device aims to reduce patient discomfort, lower costs, and lessen the burden on healthcare professionals. Its disposable format removes the need for cleaning and disinfection, while future integration with AI and digital platforms could support more accessible and efficient screening.
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions worldwide.